Our Mission

"When a child comes to us, we know our main priority is to provide the highest level of care as quickly and effectively as possible. As part of one of the largest pediatric cancer programs in the nation, Hematology/Oncology & BMT at Nationwide Children's Hospital has greater access to more clinical trials and the latest in clinical research. From the new design of our floors and units, to our Long-Term Survivors Clinic – the coming together of all of these programs has been proven to better patients’ outcomes."

Thomas Gross, MD, PhD »

Neuroblastoma

Currently, one in every 330 children in the United States develops cancer before the age of 19. Progress in the development of effective new treatments and cures for childhood cancer has been spectacular during the past three decades, but progress is beginning to plateau. Most children now can be cured if they are treated at childhood cancer treatment and research centers by teams of experts in childhood cancer.

As one of the nation’s largest cancer treatment and research centers, Nationwide Children's is leading the fight against childhood cancer, determined to beat it in all its forms. The Cancer Center at Nationwide Children's Hospital provides comprehensive, multidisciplinary diagnosis, treatment and long-term management for pediatric and adolescent patients with any type of cancer.

To learn more about how we can help you and your child, click the links below:

News & Highlights

Multi-Center Pilot Study for Neuroblastoma

Sandeep Soni, MD, has developed a multi-center pilot study for neuroblastoma. The primary goal of the study is to identify what toxicity patients acquire when they receive an allogeneic stem cell transplant by using a reduced intensity regimen and whether it leads to an improvement in the survival of patients with refractory or relapsed neuroblastoma. All the patient-study data will be collected and stored at Nationwide Children’s and approximately 25 children or adolescents will participate in the study.